| DB ID | MyCo_4319 |
| Title | Immunoproteomics based identification of thioredoxin reductase GliT and novel Aspergillus fumigatus antigens for serologic diagnosis of invasive aspergillosis |
| Year | 2012 |
| PMID | 22251604 |
| Fungal Diseases involved | Invasive aspergillosis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | The study protocol was approved by the Ethics Committee of the hospital and informed consent was obtained from all patients included in the study |
| Site of Infection | Unspecified |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Fumarylacetoacetate hydrolase FahA |
| Biomarker Full Name | Fumarylacetoacetate hydrolase FahA |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | China |
| Cohort | Six patients with proven IA, and different underlying dis- eases and expressing high levels of anti-Aspergillus antibo-dies were selected for the immunoproteomic analysis. |
| Cohort No. | 6 |
| Age Group | 30-65 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Proteomics |
| Technique | Computational |
| Analysis Method | Immunoproteomics Approach |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunoproteomics Approach |
| Up Regulation Down Regulation | Positive |
| Sequence Data | GenBank Accession No: GI:70989411 |
